Eur J Med Res. 2025 Dec 5;30(1):1211. doi: 10.1186/s40001-025-03439-w.
ABSTRACT
Non-obstructive myocardial stunning is characterized by transient myocardial contractile dysfunction despite preserved coronary perfusion. Although increasingly recognized, it remains a diagnostic and therapeutic challenge in cardiology. This review synthesizes current insights into reversible cardiomyopathies, explores the potential of antimetabolic and anti-ischemic agents in their management, and highlights emerging therapeutic avenues. Greater understanding of these mechanisms may improve patient outcomes in this underexplored area.
PMID:41351131 | DOI:10.1186/s40001-025-03439-w